InvestorsHub Logo

roiresearch

08/24/20 8:21 AM

#320016 RE: DaubersUP #320010

Last Paragraph says a lot - he should have broken this up into 2 PRs today

Interactions with the Food and Drug Administration, through its Coronavirus Treatment Acceleration Program, are anticipated to begin early September, along with the selection of a Contract Research Organization to implement the Brilacidin for COVID-19 clinical trial.

Lastly, the manufacturing of Brilacidin intravenous (IV) drug product is expected to produce an amount in excess of what is estimated to be required for the Company’s planned Phase 2 clinical trial, allowing for extra IV drug product to support potential additional COVID-19 clinical testing.



They already know the dosing according to this last sentence.

and also

This last part suggest possible compassionate use if there is a 2nd wave IMHO